Jessica M. Stempel
@JMStempel
Followers
240
Following
862
Statuses
166
Heme/Onc fellow @Yale @YaleHemOnc l @ASH_hematology Trainee Council 2022-2024 l @EinsteinHealth IM resident/chief l MD-UCV 🇻🇪 - views are my own
Connecticut, USA
Joined May 2021
0
5
0
RT @YaleCancer: Dr. Nikolai Podoltsev presents @eaonc E1910 Ph III trial of the addition of Blinatumomab to consolidation therapy for older…
0
4
0
RT @YaleCancer: Celebrating Dr. Jennifer Afranie-Sakyi, @YaleHemOnc, and her presentation of implementation rates of the @ASH_hematology ce…
0
5
0
RT @tariqkewan: Had an amazing time at #ASH2024 meeting friends, attending great talks and finally getting the great news of passing my Hem…
0
5
0
RT @Dr_AmerZeidan: Dr Luca Lanino @YaleCancer @HumanitasMilano presenting an excellent project that developed a molecular classification &…
0
4
0
RT @YaleCancer: .@KunalPotnis reveals that at the current pricing, eltrombopag plus traditional immunosuppressive therapy is unlikely to be…
0
9
0
0
0
2
@XimeJordan @ASH_hematology @LatinasInMed Thank you @XimeJordan @PamChMD !! Love meeting and connecting with colleagues at #ASH24 @ASH_hematology !! @LatinasInMed
0
0
3
Excited to share our work! Thank you @Dr_AmerZeidan @Dr_RoryShallis for your mentorship and support!
Dr @JMStempel fantastically presented our investigator-initiated randomized phase 2 trial of aza-ven +/- Pembro in older #AMLsm #ASH24 which was unfortunately -ve but showed importance of using ELN2024 for risk stratification & feasibility of central MRD in primary endpoint #IMG
1
4
20
RT @YaleCancer: An overview of treatment patterns & outcomes of CAR-T & Bispecific T-Cell Engager BiTE therapies in Relapsed/Refractory #Mu…
0
4
0
Incredible work by @Alhajahjeh_Abd !!
Thank you @Dr_AmerZeidan for all the great support you give me I will make sure to be at the intended level.
1
0
2
RT @LaylaDoren1: What an honor to speak on incorporating health equity into UGME at this years #ASH24 medical educators symposium.
0
5
0
RT @drkelseymartin: Beautiful run! @JMStempel @NataliaNeparid1 @YaleHematology @YaleHemOnc #ASH24 #ASH5K
0
4
0
RT @YaleCancer: .@JMStempel & Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor + Eltrombopag is effective in r…
0
8
0
RT @XimeJordan: It was a pleasure to participate in this rapid mentoring sessions! Always happy to contribute even with encouraging words i…
0
2
0
RT @LaraKimR: @Dr_AmerZeidan @YaleMed @Alhajahjeh_Abd Wondering why so many clinical trials end prematurely? Our latest research digs into…
0
5
0
RT @vale_restrepo1: 🚨Calling all Hematology & Oncology doctors! Please take this 5-minute survey on grit and resilience ➡
0
8
0